Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Expert Opinion on Therapeutic Targets|May 30, 2018
Alopecia areata and the gut-the link opens up for novel therapeutic interventionsAnnika Borde, Annika Åstrand
Pharmacology & Therapeutics|May 27, 2017
Mechanisms of tolerance and potential therapeutic interventions in Alopecia AreataGabriel Skogberg, Sonya Jackson, Annika Åstrand
Expert Opinion on Therapeutic Patents|November 5, 2016
Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 2Jason G Kettle, Annika Åstrand, Matthew Catley, et al.
Expert Opinion on Therapeutic Patents|November 8, 2016
Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 1Jason G Kettle, Annika Åstrand, Matthew Catley, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|January 12, 2013
Electrophysiological characterization and antiarrhythmic efficacy of the mixed potassium channel-blocking antiarrhythmic agent AZ13395438 in vitro and in vivoIngemar Jacobson, Göran Duker, Malin Florentzson, et al.
European Journal of Pharmacology|May 11, 2021
New generation ENaC inhibitors detach cystic fibrosis airway mucus bundles via sodium/hydrogen exchanger inhibitionMelania Giorgetti, Nikolai Klymiuk, Andrea Bähr, et al.
Journal of Pulmonary & Respiratory Medicine|June 26, 2018
Differential Effect of LPS on Glucose, Lactate and Inflammatory Markers in the Lungs of Normal and Diabetic MiceCecilia Nagorny Holmberg, Annika Åstrand, Cecilia Wingren, et al.
Plos One|September 10, 2019
Correction: Alopecia areata patients show deficiency of FOXP3+CD39+ T regulatory cells and clonotypic restriction of Treg TCRβ-chain, which highlights the immunopathological aspect of the diseaseFatma N Hamed, Annika Åstrand, Marta Bertolini, et al.
Annals of the American Thoracic Society|November 14, 2023
Effect of COVID-19 on Bronchiectasis Exacerbation Rates: A Retrospective U.S. Insurance Claims StudyAnnika Åstrand, Steven J Kiddle, Rohith Siva Ganesh Mudedla, et al.
Plos One|July 6, 2019
Alopecia areata patients show deficiency of FOXP3+CD39+ T regulatory cells and clonotypic restriction of Treg TCRβ-chain, which highlights the immunopathological aspect of the diseaseFatma N Hamed, Annika Åstrand, Marta Bertolini, et al.
Pageof 3